Tony's Takeaway: Riding that speculative stock
He also delves into the psychology of speculation and provides regular insights on a number of social media and finance related outlets.
In this edition, Tony looks at the colourful journey of small cap investing, the stops on the way and the exciting times ahead as we get well into this second quarter.
The views, information, or opinions expressed in this video are solely those of the author and do not represent the views of Stockhead.
Stockhead has not provided, endorsed or otherwise assumed responsibility for any financial product advice contained in this video. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
SBS Australia
23 minutes ago
- SBS Australia
Systemic barriers locking Australia's First Nations peoples out of superannuation
New research has found the nation's $4 trillion superannuation system is failing Indigenous people. The independent research was commissioned by Super Consumers Australia with Mob Strong Debt Help and Impact Economics and Policy. It's found they are twice as likely to be unable to access their superannuation, due to systemic barriers including rigid policies, inaccessible customer service and a lack of accountability. These barriers are things like rigid ID verification, digital-only processes and a lack of cultural understanding. Alex Price-Busch is the Financial Counsellor at Indigenous Consumer Assistance Network (ICAN). He's told NITV there's an urgent need for reform. "Time and time again in our case work we have clients present to access money from - whether it's their own super that's been lost or for a family member who's passed away - and the amount of information required and in a lot of circumstances that's also legal requirements that they need to meet that they simply can't afford even to access smaller amounts of money." He says ICAN aims to create ways for First Nations people to navigate the system and engage more confidently. "One of the things the report has pushed for is to have a minimum set of customer service standards for super companies and their First Nations clients, I think that will be a great starting point. In addition to that, I think there will need to be better alternatives for things that take into consideration into differences for people that live in those remote communities, whether that is around digital literacy, or even their ability to make a phone call." Mark Holden is the Senior Solicitor from Mob Strong Debt Help. He's told SBS World News their statistics suggest only 69 per cent of First Nations consumers have a superannuation fund, compared to 87 per cent for their non-First Nations consumers. But for those who do have a super fund, rigid ID verification rules, culturally unsafe customer service and a reliance on digital-only processes means it can take months or even years to access their own money, if they are still alive. He says they also found First Nations consumers have a typical balance of less than $22,000 compared to $66,000 for non-First Nations consumers. "We see generations of First Nations consumers who aren't able to access their own money. This is money that's been held on trust for them during their time of need whether that may be for financial hardship, retirement or to pass on to the next generation." Mr Holden says many are denied access to their own money in retirement, during financial hardship or after the death of a loved one. The report also calls for adequately resourcing financial counselling and legal support on superannuation issues for First Nations peoples. "Any delay that we have prolongs intergenerational trauma that we give our mob and because this is the money that belongs to them, it belongs to them after their hard work over the years and it's supposed to be held in trust for them. It will be completely unreasonable and even unconscionable for super funds to be able to continue to circulate without providing First Nations consumers the help they need to be able to access their money when they need it." His advice to First Nations people would be to visit the government's Money Smart platform online or to speak to a local counsellor. He says it's important for them to take some time to go through their own super funds to see how they can access and prove their identity, and also for First Nations people to list their super beneficiaries.
ABC News
23 minutes ago
- ABC News
Markets live updates: Tesla quarterly revenue slumps in sharpest fall in a decade, ASX to lift
Electric vehicle maker Tesla misses expectations with its quarterly results, which analysts are labelling disappointing, as its revenue drops 12 per cent, the sharpest decline in more than a decade. The ASX is set to rise following gains on Wall Street, and the local focus will be on a speech by RBA governor Michele Bullock later today. Follow the day's financial news and insights from our specialist business reporters on our live blog. Disclaimer: this blog is not intended as investment advice.
News.com.au
44 minutes ago
- News.com.au
Why former Ramsay boss sees EMVision's portable stroke detection tech as game-changing
Former Ramsay boss and new EMVision director Carmel Monaghan believes its early stroke detection tech can transform lives Monaghan says EMVision is filling a gap in the market which could improve stroke outcomes Leading stroke centres in Australia and US taking part in pivotal trial for EMVision's first device, the emu bedside scanner EMVision's newest high-profile board director Carmel Monaghan believes the company's technology for early detection of stroke has the potential to "transform people's lives". Monaghan, who has joined the EMVision board as a non-executive director, stepped down this month from Ramsay Health Care (ASX:RHC) after five years as CEO of Ramsay Australia. Ramsay is Australia's largest private hospital operator and offers a range of multidisciplinary healthcare services along with extensive operations internationally. "EMVision is filling a gap in the market, and I've been impressed with the level of research undertaken over the last seven or eight years to bring rapid portable stroke sensing and imaging to point of care, which will really transform people's lives," Monaghan told Stockhead. "We know that time is brain in stroke diagnostics so getting quick, easy access to that neurodiagnostic solution can lead to a much-improved outcome." EMVision is currently undertaking a pivotal trial to support US Food and Drug (FDA) de novo (new device) clearance for its first commercial device – the emu bedside scanner – which is designed to rapidly diagnose stroke at the point-of-care. If granted clearance emu is anticipated to become the predicate device for its second device, First Responder, allowing an expedited 510(k) FDA pathway for the pre-hospital market. Leading stroke centres in Australia and the US are taking part in the trial including Mount Sinai Hospital in New York, Houston's Memorial Hermann-Texas Medical Center and the Mayo Clinic in Florida. EMV is also advancing a strategy to drive ongoing device innovation, refine its algorithms and generate data to support potential expansion of indications to include traumatic brain injury (TBI). This work forms part of EMVision's Continuous Innovation Study, which has received ethics approval to start scanning patients with suspected stroke or TBI at Brisbane's Princess Alexandra Hospital and Newcastle's John Hunter Hospital – both high-volume, comprehensive stroke and level-one trauma centres. Interest in advancing medical innovation Monaghan brings nearly 30 years of experience across hospital, corporate, and international roles at Ramsay. Before becoming CEO in 2020, she served as group chief of staff for Ramsay's global operations, gaining deep operational and strategic insight into the healthcare sector in both Australia and overseas. Monaghan also held the role of group head of marketing and public affairs, where she led the company's marketing, brand and communications strategy during a period of significant global expansion that saw Ramsay become one of the world's leading private healthcare operators. "I'm passionate about enhancing patient care through emphasising and embedding research and clinical trials into operations," Monaghan said. "I drove the expansion of clinical trials at Ramsay because I could see how this made a difference to clinical outcomes and people's lives. "At any one time, we had more than 250 clinical trials being undertaken at Ramsay facilities. "I am really interested in getting research to implementation and giving people hope and that has been a big passion of mine and what I love about medicine." Monaghan emphasised that whether it's drugs or devices, the goal is the same – to test and prove their impact, ultimately improving not just mortality rates but quality of life for people living with the burden of disease. "I've seen it with cancer drugs, robotic technology and that is what attracted me to EMVision. "It is health innovation with purpose and impact." World-renowned clinical team Monaghan noted EMVision's impressive technical, clinical and leadership team. She joins vastly experienced clinicians, medtech and business leaders on the board. The company's clinical advisory group also includes world-leading clinicians, working to address a strong clinical need. "EMVision have world-leading neurologists advising them along with huge luminary hospitals in the US like Mayo and Mt Sinnai, which are now scanning and enrolling patients,' she said, noting there are around 12.5 million strokes globally each year with 6.5 million dying annually. "It is a big burden of disease and one in four people globally over 25 will have a stroke in their lifetime, which has increased 50% over the past 17 years. "With stroke every minute counts and the outcome is heavily influenced by how quick the treatment is delivered. "Both the emu and First Responder will fill a gap where CT is just not practical and means the clinician who needs to make a quick treatment decision can do that effectively." She added that in the future there will also be interest in how the devices could be used to promptly diagnose TBI. "That is down the track, but it has great potential with studies underway at the John Hunter and the Princess Alexandra Hospital that will allow us to begin evaluating traumatic brain injury using our technology." Australia's global edge in health innovation Mongahan said Australia had long punched above its weight in health innovation, producing homegrown companies that have made a global impact. From hospitals to high-tech medical devices, the nation has cultivated a strong foundation in scientific research and clinical excellence – factors that continue to drive international success. She pointed to ASX-listed healthcare heavyweights such as Ramsay, blood products leader CSL (ASX:CSL), hearing implant pioneer Cochlear (ASX:COH), diagnostics and imaging specialist Sonic Healthcare (ASX:SHL), and sleep disorder device manufacturer ResMed (ASX:RMD) as world-class companies. "I have always admired how fantastic Australia is with healthcare and it's because we have such well-trained doctors and good scientific research," she said. "They've all been amazing, admirable companies which have been able to successfully transition overseas. "I think it's exciting how Australia has always performed so strongly in the health field, driven by world-class scientific research and highly trained medical professionals." At Stockhead, we tell it like it is. While EMVision is a Stockhead advertiser, it did not sponsor this article.
